Streetbeat News

Products Services

NVCR

ZLAB

NovaCure announced positive results from its Phase 3 LUNAR clinical trial, which evaluated the use of Tumor Treating Fields therapy combined with standard treatment therapies. The trial met its primary endpoint at the 2023 ASCO Annual Meeting.

Portfolio Pulse from Charles Gross

June 06, 2023 | 12:08 pm

BLFS

BioLife Solutions has launched the IntelliRate i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer, a new product designed to improve the freezing process for biologic materials. The i67C offers precise temperature control and monitoring, enhancing the quality and viability of stored samples.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:05 pm

HOTH

Hoth Therapeutics announced positive preclinical results for its HT-ALZ treatment in Alzheimer's disease, showing improvements in cognitive function. The company's stock, HOTH, may be impacted by this news.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:04 pm

ACB

Aurora Cannabis is launching a new lineup of marijuana products in Canada this summer, including edibles and vape pens. The company has also introduced Aurora Lab, a research and education program aimed at gathering insights for future product development.

Portfolio Pulse from Vuk Zdinjak

June 06, 2023 | 12:03 pm

F

TSLA

Ford CEO Jim Farley compared Tesla's heavy discount strategy to Henry Ford's Model T pricing mistake, which nearly led to bankruptcy. Tesla's price cuts have boosted Q1 deliveries but may reduce demand elasticity.

Portfolio Pulse from Anan Ashraf

June 06, 2023 | 11:45 am

FRZA

Forza X1 shares are up 30% premarket after the company announced the FORZA X1 ELECTRIFIED event, scheduled for Saturday, July 8th, 2023.

Portfolio Pulse from Charles Gross

June 06, 2023 | 11:41 am

PTGX

Protagonist Therapeutics has reported the acceptance of a late-breaking abstract for an oral presentation at the 2023 European Hematology Association (EHA) Congress. The EHA will also feature two additional presentations from the company's rusfertide peptide therapeutic development program, including new data and updates in polycythemia vera.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 11:35 am

AVXL

Anavex Life Sciences has completed its ANAVEX 2-73 EXCELLENCE Phase 2/3 Rett Syndrome clinical trial. The trial aims to evaluate the safety and efficacy of the drug in treating Rett Syndrome, a rare neurological disorder.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 11:32 am

AMZN

VSCO

Victoria's Secret and Amazon Fashion have expanded their collaboration, launching a cross-category shopping experience with over 4,000 items available on the Victoria's Secret Amazon Fashion storefront, including fast, free Prime delivery.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 11:31 am

NVAX

Novavax's R&D Chief Filip Dubovsky announced that their new COVID-19 vaccine is likely to protect against fast-growing variants. This development could potentially increase the demand for Novavax's vaccine.

Portfolio Pulse from Charles Gross

June 06, 2023 | 11:29 am